Detalles de la búsqueda
1.
Systematic literature review of real-world evidence for treatments in HR+/HER2- second-line LABC/mBC after first-line treatment with CDK4/6i.
BMC Cancer
; 24(1): 631, 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38783218
2.
A targeted review of worldwide indirect treatment comparison (ITC) guidelines and best practices.
Value Health
; 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38843980
3.
Efficacy and safety of crizotinib in the treatment of advanced non-small cell lung cancer with ROS1 gene fusion: a systematic literature review and meta-analysis of real-world evidence.
Lung Cancer
; 192: 107816, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38749072
4.
Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons.
Ther Adv Neurol Disord
; 17: 17562864241239453, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38525490
5.
The impact of race on survival in metastatic prostate cancer: a systematic literature review.
Prostate Cancer Prostatic Dis
; 26(3): 461-474, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592001
6.
Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis.
J Comp Eff Res
; 12(7): e230016, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37265062
7.
Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma.
Curr Med Res Opin
; 39(1): 81-89, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36271807
8.
Aerobic training as an adjunctive therapy to enzyme replacement in Pompe disease.
Mol Genet Metab
; 107(3): 469-79, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23041258
9.
Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis.
Mult Scler Relat Disord
; 66: 104031, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35841716
10.
Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma.
Curr Med Res Opin
; 38(10): 1759-1767, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35815818
11.
Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses.
Curr Med Res Opin
; 37(11): 1933-1944, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34384311
12.
Efficacy classification of modern therapies in multiple sclerosis.
J Comp Eff Res
; 10(6): 495-507, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33620251
13.
Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis.
Breast
; 57: 5-17, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33677313
14.
Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma.
Curr Med Res Opin
; 37(10): 1779-1788, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34256668
15.
The impact of clinical heterogeneity on conducting network meta-analyses in transthyretin amyloidosis with polyneuropathy.
Curr Med Res Opin
; 36(5): 799-808, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32011182
16.
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis.
J Comp Eff Res
; 9(18): 1255-1274, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33090003
17.
The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis.
Curr Med Res Opin
; 36(7): 1145-1156, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32216597
18.
Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis.
Curr Med Res Opin
; 36(7): 1157-1166, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32220214
19.
Endurance training without weight loss lowers systemic, but not muscle, oxidative stress with no effect on inflammation in lean and obese women.
Free Radic Biol Med
; 45(4): 503-11, 2008 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18502211
20.
A neuromuscular approach to statin-related myotoxicity.
Can J Neurol Sci
; 35(1): 8-21, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18380273